Home › Linfoma a cellule del mantello › North Carolina › Durham
Studi clinici su Linfoma a cellule del mantello a Durham, NC
13 studi su Linfoma a cellule del mantello cercano partecipanti presso sedi a Durham e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
In reclutamentoFase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · a 10 mi di distanza
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
In reclutamentoFase 3
- Duke University, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
In reclutamentoFase 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · a 10 mi di distanza
DALY II USA/ MB-CART2019.1 for DLBCL
In reclutamentoFase 2
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
In reclutamentoFase 1
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
In reclutamentoFase 1
- Duke Univerisity, Durham
Study of SGR-1505 in Mature B-Cell Neoplasms
In reclutamentoFase 1
- Duke University, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
In reclutamentoFase 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · a 10 mi di distanza
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
In reclutamentoFase 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Chapel Hill · a 10 mi di distanza
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
In reclutamentoStudio osservazionale
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · a 10 mi di distanza
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
In reclutamentoFase 1
- University of North Carolina, Chapel Hill · a 10 mi di distanza
Studi su Linfoma a cellule del mantello in altre città
- Houston, TX15 studi
- Baldwin Park, CA15 studi
- New York City, NY12 studi
- Seattle, WA12 studi
- Milwaukee, WI12 studi
- Boston, MA11 studi
- Nashville, TN11 studi
- Columbus, OH11 studi
- Chicago, IL10 studi
- Rochester, MN9 studi
- Portland, OR9 studi
- Atlanta, GA8 studi
Altri studi a Durham
- Cancro al seno64 studi
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule39 studi
- Mieloma multiplo37 studi
- Leucemia mieloide acuta33 studi
- Cancro metastatico33 studi
- Cancro alla prostata32 studi
- Cancro ai polmoni32 studi
- Cancro colorettale28 studi
- Cancro ovarico27 studi
- Leucemia linfatica cronica27 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.